TTD | Drug: D0RL5B

Drug General Information
Drug ID	D0RL5B
Former ID	DIB012311
Drug Name	VLB-01
Indication	Epilepsy [ICD10:G40]		Phase 3	[549135]
Company	Marco Polo Pharmaceuticals SA
Target and Pathway
Target(s)	Melatonin receptor type 1B	Target Info	Modulator	[1572591]
KEGG Pathway	Neuroactive ligand-receptor interaction
KEGG Pathway	Circadian entrainment
Reactome	Class A/1 (Rhodopsin-like receptors)
Reactome	G alpha (i) signalling events
WikiPathways	GPCRs, Class A Rhodopsin-like
	Small Ligand GPCRs
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 549135	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032715)
Ref 1572591	Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

Drug Information